We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-6.1%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$13.5M
AUM Growth
-$1.55M
Cap. Flow
+$17.1M
Cap. Flow %
126.71%
Top 10 Hldgs %
54.64%
Holding
84
New
22
Increased
18
Reduced
8
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$801K
2
WEAV icon
Weave Communications
WEAV
+$715K
3
VKTX icon
Viking Therapeutics
VKTX
+$662K
4
SRG
Seritage Growth Properties
SRG
+$385K
5
ML
MoneyLion Inc.
ML
+$305K

Top Sells

Rank Stock Value
1
AIP icon
Arteris
AIP
+$1.01M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$908K
3
INSM icon
Insmed
INSM
+$597K
4
APLS
Apellis Pharmaceuticals
APLS
+$453K
5
NVO
Novo Nordisk
NVO
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 30.58%
2 Real Estate 24.99%
3 Technology 20.99%
4 Communication Services 7.7%
5 Financials 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$634B
$1.33M 9.86%
9,100
– –
WEAV icon
2
Weave Communications
WEAV
$491M
$1.3M 9.61%
143,713
+73,459
+105% +$715K
ITI
3
DELISTED
Iteris, Inc.
ITI
$815K 6.05%
188,327
+12,289
+7% +$55.6K
PFE icon
4
Pfizer
PFE
$140B
$814K 6.04%
+29,100
New +$801K
RDCM icon
5
Radcom
RDCM
$218M
$721K 5.35%
77,163
+18,072
+31% +$171K
SSTI icon
6
SoundThinking
SSTI
$107M
$593K 4.4%
48,667
+1,683
+4% +$23.9K
VKTX icon
7
Viking Therapeutics
VKTX
$4.04B
$535K 3.97%
+10,100
New +$662K
CTO
8
CTO Realty Growth
CTO
$743M
$529K 3.92%
30,302
+2,000
+7% +$34.6K
WSR
9
DELISTED
Whitestone REIT
WSR
$383K 2.84%
28,750
+1,400
+5% +$17.2K
EQC
10
DELISTED
Equity Commonwealth
EQC
$350K 2.6%
18,053
– –
EPR icon
11
EPR Properties
EPR
$4.86B
$317K 2.35%
7,550
+200
+3% +$8.23K
PLYM
12
DELISTED
Plymouth Industrial REIT
PLYM
$312K 2.32%
14,600
– –
ML
13
DELISTED
MoneyLion Inc.
ML
$286K 2.12%
+3,887
New +$305K
SEZL
14
Sezzle
SEZL
$5.17B
$270K 2%
+18,348
New +$214K
ALNY icon
15
CALL
Alnylam Pharmaceuticals
ALNY
$36.3B
$259K 1.92%
+4,400
New +$695K
KRG icon
16
Kite Realty
KRG
$5.95B
$257K 1.91%
11,500
– –
ALCO icon
17
Alico
ALCO
$286M
$255K 1.89%
9,838
+1,500
+18% +$40.6K
ADC icon
18
Agree Realty
ADC
$9.68B
$251K 1.86%
4,050
– –
SPG icon
19
Simon Property Group
SPG
$74.5B
$250K 1.86%
1,650
– –
AIOT
20
PowerFleet Inc
AIOT
$500M
$250K 1.85%
54,643
-1,601
-3% -$7.6K
SRG
21
Seritage Growth Properties
SRG
$130M
$248K 1.84%
+53,000
New +$385K
ZETA icon
22
Zeta Global
ZETA
$4.77B
$240K 1.78%
+13,597
New +$199K
BDN
23
Brandywine Realty Trust
BDN
$551M
$237K 1.76%
53,000
+3,000
+6% +$13.7K
NSA
24
DELISTED
National Storage Affiliates Trust
NSA
$235K 1.74%
5,700
-1,200
-17% -$45.2K
PLYA
25
DELISTED
Playa Hotels & Resorts
PLYA
$194K 1.44%
23,100
– –
1
2 3 4

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Worth Venture Partners held 84 positions worth $13.5M, down 10% from $15M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Worth Venture Partners deployed $17.1M of net new capital in Q2 2024, opening 22 new positions and adding to 18 existing holdings. Its largest new stake was Pfizer: 29,100 shares worth $814K.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Innovid Corp., an estimated $64.2K trimmed.

  • Worth Venture Partners's largest Q2 2024 buy was Pfizer: 29,100 shares worth $814K.
  • Worth Venture Partners added most to Weave Communications in Q2 2024, an estimated $715K increase.
  • Worth Venture Partners's biggest Q2 2024 reduction was Innovid Corp., cutting an estimated $64.2K.
  • Worth Venture Partners fully exited Arteris in Q2 2024, selling an estimated $1.01M.
  • Worth Venture Partners's ten largest holdings make up 55% of its $13.5M portfolio in Q2 2024.
  • Worth Venture Partners opened 22 new positions and closed 28 in Q2 2024.
  • Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $13.5M.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.